New drug approved for treating chronic schizophrenia with fewer side effects. Could be beneficial for Black community.

Licensing deals have risen in prominence in a restrained market environment. Is it desperation, or an important part of the ...

The FDA wrapped up 2024 with 50 new drug approvals, clearing a wave of long-awaited treatments. Meanwhile, Transcarent will ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

Scientists have characterized the role of thousands of mutations in the BRCA2 cancer gene, findings that may help reassure ...

An international team of UK and US scientists has discovered that the activity of macrophages – a type of white blood cell that engulf pathogens and cancer cells – can be used to predict whether or ...

This was the stock's second consecutive day of gains.

By Sneha S K and Sriparna Roy (Reuters) - The U.S. Food and Drug Administration said on Friday that it has approved an ...

CytomX’s workforce cuts could leave the biotech with fewer than 75 employees as it focuses resources on its wholly owned ...

As Bristol gets ready to celebrate Christmas, here is our penultimate round-up of images from across the city for this year. It's pantomime season at our theatres, with varied productions for ...

Texas Children’s Global HOPE and Baylor College of Medicine Global Health, with support from the Bristol Myers Squibb ...